DNMT3A and neoplasm: Next, we assessed DNMT3A protein expression in a tissue microarray containing 128 paraformaldehyde‐fixed GBC tumor tissues using immunohistochemistry and evaluated the relationship between the expression level of DNMT3A and different clinicopathological characteristics in patients with GBC (Figure 1e).